Birdwatch Note
2023-02-01 01:08:59 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
A study found the risk of myocarditis after SARS-CoV-2 infection to be roughly 4 to 10 times the risk after the ChAdOx1 or BNT162b2 vaccines: https://doi.org/10.1161/CIRCULATIONAHA.122.059970 A case study found 370x to 9000x higher troponin levels after COVID infection vs. after COVID vaccination: https://doi.org/10.1093/clinchem/hvac100
Written by C966E0BA5803EDA2B9ADEA1A226B5D5FB13629349A2D9A920F01C5137F8AF13B
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1617223789124718601
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1620589999828910082
- noteId - 1620589999828910082
- participantId - C966E0BA5803EDA2B9ADEA1A226B5D5FB13629349A2D9A920F01C5137F8AF13B
- noteAuthorParticipantId -
- createdAtMillis - 1675213739721
- tweetId - 1617223789124718601
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- A study found the risk of myocarditis after SARS-CoV-2 infection to be roughly 4 to 10 times the risk after the ChAdOx1 or BNT162b2 vaccines: https://doi.org/10.1161/CIRCULATIONAHA.122.059970 A case study found 370x to 9000x higher troponin levels after COVID infection vs. after COVID vaccination: https://doi.org/10.1093/clinchem/hvac100
Note Ratings
rated at | rated by | |
2023-01-31 19:56:59 -0600 | 16083CF58C61826CA486F1EAB22B87395452668AD90F998EB3BEF7ECB901BF79 | Rating Details |
2023-02-27 22:19:17 -0600 | 45060ED935D102E05C21C743FE433C0B17B27D8FCF69CED01A2AD3F9AB2815B1 | Rating Details |
2023-02-28 07:14:08 -0600 | 45B8EF43682258D990F1C39DD9C1C131E030B7B116A1A874CAD37AED55F98C04 | Rating Details |
2023-02-28 06:14:49 -0600 | 4605513EC1424AD757F5463A7F46AB79E0D8A3C4C30264133BEF4225D384F295 | Rating Details |
2023-01-31 21:14:06 -0600 | 48FA6B8E2CB1EF7355F7BE7CC57590CA346D697F937703BAE794D804E88FAE67 | Rating Details |
2023-01-31 19:59:39 -0600 | 4FC926E5911CED55C5AA42BC4C5F605291B9748A034501A6E40780088EBC50B1 | Rating Details |
2023-01-31 21:49:05 -0600 | 5794EE496C1EDE35167B84C87740F7BACF2C09121B3E43869520EEAF31819C7A | Rating Details |
2023-01-31 20:06:27 -0600 | 992932B0527A672C23AE61796C01072F45C13496756A150528BB74653898B6D4 | Rating Details |
2023-01-31 21:04:14 -0600 | 9B5E7654114B589A3A4E99761C67F6947C8929874AA1F71C4EBE23FA3F1CCB69 | Rating Details |
2023-01-31 19:38:54 -0600 | 9F727D03EB3486219A34406652693BEC82B9193E703FA0E17CF7881F79761060 | Rating Details |
2023-02-28 06:31:34 -0600 | A30E23B01F927C4387616E33DE422C96B4F9A9B45B8ACA619267391F3D77B5A8 | Rating Details |
2023-02-28 03:14:06 -0600 | B289B7B9A72A2B21A5016714B5CFECC892B67D4EF528AD49D229201250F7B83A | Rating Details |
2023-02-28 05:48:15 -0600 | B5FEE1C7F02671E2466AE0184315222BE9F827034DA0D608839BE86F8B7D554A | Rating Details |
2023-01-31 19:13:01 -0600 | BAF0C3FA9C1CE1DA64F07804AF7C7E25503BB91C5E0FAB0110A67821B0D2281B | Rating Details |
2023-02-27 21:13:35 -0600 | BFB2F3AC7C706EEFEEFE5CD74F6E43EDE24CC6BB8833E44660FC2E5C5D200776 | Rating Details |
2023-02-07 20:37:36 -0600 | C378931E048482D2BFDF00DC95644D6377CBCB812C79FF87D77B5E48595B3DA3 | Rating Details |
2023-01-31 19:46:49 -0600 | D45A2C2D0A01452EB4CAC563989CA4D4828760FB2A92310BCB8E87CE1A83E5A9 | Rating Details |
2023-01-31 20:36:54 -0600 | EF5838C34D157700B871CE6CFBA36757ACAFDD327E2BB76928343F38A58BDAAB | Rating Details |
2023-02-28 04:29:44 -0600 | F810B9A117A15B206340CC72B29D65263DC4B812622393BFCBE22D0EE5EE3DFF | Rating Details |
2023-02-28 05:09:24 -0600 | Rating Details | |
2023-02-01 08:32:23 -0600 | Rating Details | |
2023-01-31 21:04:14 -0600 | Rating Details | |
2023-01-31 20:36:54 -0600 | Rating Details | |
2023-02-28 07:14:08 -0600 | Rating Details | |
2023-02-28 05:09:24 -0600 | Rating Details | |
2023-02-28 06:14:49 -0600 | Rating Details | |
2023-01-31 19:46:49 -0600 | Rating Details | |
2023-02-28 05:48:15 -0600 | Rating Details | |
2023-02-07 20:37:36 -0600 | Rating Details | |
2023-02-27 22:19:17 -0600 | Rating Details | |
2023-01-31 20:06:27 -0600 | Rating Details | |
2023-02-27 21:13:35 -0600 | Rating Details | |
2023-01-31 21:14:06 -0600 | Rating Details | |
2023-02-01 08:32:23 -0600 | Rating Details | |
2023-02-28 06:31:34 -0600 | Rating Details | |
2023-02-28 04:29:44 -0600 | Rating Details | |
2023-01-31 19:13:01 -0600 | Rating Details | |
2023-02-28 03:14:06 -0600 | Rating Details | |
2023-01-31 19:56:59 -0600 | Rating Details | |
2023-01-31 19:38:54 -0600 | Rating Details | |
2023-01-31 19:59:39 -0600 | Rating Details | |
2023-01-31 21:49:05 -0600 | Rating Details | |
2023-06-23 05:06:15 -0500 | Rating Details |